Related by context. All words. (Click for frequent words.) 74 multi kinase inhibitor 73 orally administered inhibitor 73 targeted radiotherapeutic 73 PNP inhibitor 72 AEG# 72 CYT# potent vascular disrupting 72 Aflibercept 72 OMP #M# 72 IMiDs ® 72 IAP inhibitor 72 oral prodrug 72 AAG geldanamycin analog 72 IMiDs R 72 Romidepsin 71 Tyrima 71 Annamycin 71 dasatinib Sprycel ® 71 triggers apoptosis programmed 71 vinca alkaloid 71 lintuzumab SGN 71 rALLy clinical trial 71 receptor tyrosine kinase inhibitor 71 IAP inhibitors 71 pan HDAC inhibitor 71 Phase 2b Clinical Trial 71 acyclovir Lauriad R 71 HQK 71 aflibercept VEGF Trap 70 VEGFR2 inhibitor 70 alpha folate receptor 70 YONDELIS 70 IgG1 monoclonal antibody 70 Personalized Immunotherapy 70 Sapacitabine 70 metastatic colorectal 70 IMiDs ® compound 70 alvespimycin 70 bevacizumab Avastin ® 70 PEGylated Fab fragment 70 Myocet 70 refractory chronic lymphocytic 70 Panzem R NCD 70 docetaxel Taxotere R 70 cetuximab Erbitux R 70 Lixivaptan 70 Meets Primary Endpoint 70 novel tubulin binding 70 Panzem R 70 humanised monoclonal antibody 70 PNT# 70 agonistic human 70 Cloretazine 70 kidney urologic 70 Omacetaxine 70 phase III isavuconazole 70 ENMD # 70 cell lymphoma CTCL 70 Cutaneous T 70 IL# PE#QQR 70 Factor VIIa 70 non nucleoside inhibitor 70 TOCOSOL Camptothecin 70 peptidic compound 70 Pertuzumab 69 mertansine 69 lenalidomide Revlimid R 69 Nanobody 69 Peginterferon alfa 2b 69 recurrent glioblastoma multiforme 69 MAGE A3 ASCI 69 luteinizing hormone releasing 69 LHRH receptor positive 69 systemic RNAi therapeutic 69 Cannabinor 69 Initiates Enrollment 69 erlotinib Tarceva ® 69 IMA# 69 investigational monoclonal antibody 69 Elotuzumab 69 Degarelix 69 FUSILEV enhances 69 Sudhir Agrawal D.Phil 69 thalidomide Thalomid 69 dihydrochloride Tablets 69 selective kinase inhibitor 69 telomerase therapeutic 69 recurrent metastatic ovarian cancer 69 GVAX ® 69 Aplidin 69 systemic anaplastic large 69 Enzastaurin 69 hormone LHRH antagonist 69 cutaneous T 69 MGd 69 GRN# 69 MKC# MT 69 evaluating picoplatin 69 cediranib 69 FOLOTYN ® 69 dasatinib Sprycel 69 therapeutic monoclonal antibody 69 mapatumumab 69 apoptosis proteins 69 PDE4 inhibitor 69 TRO# 69 cMET 68 generation Hsp# inhibitor 68 ALN PCS 68 novel peptide 68 radiation sensitizer 68 selective androgen receptor modulator 68 humanized therapeutic 68 Vidaza azacitidine 68 Daclizumab 68 novel immunomodulatory 68 Pegloticase 68 Vandetanib 68 vinorelbine tartrate 68 progressive metastatic prostate 68 midstage clinical 68 investigational humanized monoclonal antibody 68 selective modulator 68 HGS ETR2 68 Angiocept 68 evaluating tivozanib 68 KSP inhibitor 68 galiximab 68 NPC 1C 68 PDE# 68 virus HCV protease inhibitor 68 PSMA ADC 68 pralatrexate injection folate analogue 68 Vicriviroc 68 5 Fluorouracil 68 5 HT4 68 metaglidasen 68 ELACYT 68 myelodysplastic myeloproliferative diseases 68 pertuzumab 68 Phase #b/#a clinical 68 CCR9 antagonist 68 chimeric monoclonal antibody 68 5 fluorouracil leucovorin 68 intravesical infusion therapy 68 Tarceva TM 68 R Saizen R 68 anionic backbone 68 immunotherapeutic agent 68 midstage trials 68 mTOR mammalian target 68 BRAF inhibitor 68 Tezampanel 68 Vicinium TM 68 Panzem 68 Ozarelix 68 XL# anticancer compounds 68 CYP#A# CYP#D# 68 CDK cyclin dependent 68 antibody MAb 68 Factor Receptor 68 TBC# 68 leukemia AML 68 sorafenib Nexavar 68 ADP receptor antagonist 68 TKM PLK1 68 PEG SN# 68 targeting CD# 68 relapsed leukemia 68 forodesine 68 MKC# MKC# PP 68 novel VDA molecule 68 Olaparib 68 Blinatumomab 68 Initiates Phase II 68 de novo kidney transplant 68 HSP# inhibitor 68 Silodosin 68 Cell Lymphoma CTCL 68 oral dihydropyrimidine dehydrogenase DPD 68 Initiates Phase III 68 oral picoplatin 68 MEK Inhibitor 68 Belimumab 68 mda 7 68 chemosensitizer 68 Seliciclib 68 molecular imaging radiopharmaceutical 68 Methylnaltrexone 67 relapsed MM 67 monoclonal antibody IgG1 Mab 67 R lenalidomide 67 sorafenib tablets 67 GLPG# 67 gamma secretase inhibitor 67 SNT MC# 67 highly selective endothelin 67 Ceflatonin 67 Dementia Related Psychosis 67 Phase III Pivotal 67 #I TM# 67 pan histone deacetylase 67 HGS# 67 estramustine 67 Mipomersen 67 Luteinizing Hormone Releasing Hormone 67 5 FU leucovorin 67 anti secretory 67 MT#/MEDI-# 67 lymphoid malignancies 67 Romiplostim 67 myelofibrosis polycythemia vera 67 acetonide FA 67 LymphoStat B belimumab 67 Temsirolimus 67 Gemzar gemcitabine 67 JAK2 inhibitor 67 JAK1 67 ALN VSP Phase 67 advanced carcinoid 67 gonadotropin releasing hormone GnRH 67 hormone refractory metastatic prostate 67 Fovea Pharmaceuticals subsidiary 67 class mGluR5 inhibitor 67 essential thrombocythemia ET 67 Zorbtive TM 67 ospemifene 67 Aliskiren 67 demonstrated antitumor activity 67 PF # [002] 67 MCSP respectively 67 echinocandin 67 novel histone deacetylase 67 Cetrorelix 67 Completes Patient Enrollment 67 sitaxsentan 67 Myelodysplastic Syndrome MDS 67 blood clot dissolving 67 Epratuzumab 67 5 HT2A serotonin 67 gastro intestinal inflammation 67 Antitumor Activity 67 elotuzumab 67 THR beta agonist 67 PEGylated anti 67 HER1 67 KRN# 67 JAK#/JAK# inhibitor CYT# 67 Inhaled nitric oxide 67 INSPIRE Trial Phase III 67 Archexin 67 CEQ# 67 Phase 2a Clinical Trial 67 Cloretazine ® 67 GRNVAC1 67 Pivotal Phase III 67 Talabostat 67 defensin mimetic antibiotic 67 protein tyrosine phosphatase 1B 67 including eniluracil ADH 67 ZOLINZA 67 adalimumab Humira 67 FOLFOX6 chemotherapy regimen 67 Tumour Vascular Disrupting Agent 67 Nanobody ® 67 pathophysiological effects 67 candidate deforolimus 67 phase IIb trial 67 peripherally acting 67 Investigational Treatment 67 D aspartate NMDA receptor 67 CD4 monoclonal antibody 67 acadesine 67 poly ADP ribose polymerase 67 2 methoxyestradiol 67 Squalamine 67 sunitinib Sutent 67 factor Xa 67 CYT# vascular disrupting 67 Aurora kinase 67 Pharma Merck Serono 67 delivers fluocinolone acetonide FA 67 BCR ABL inhibitor 67 bortezomib Velcade R 67 oral dual endothelin 67 HDAC Inhibitor 67 ALN HPN 67 proteasome inhibitor 67 beta 1a 67 Rigel R# 67 non porcine pancreatic 67 Kinase Inhibitor 67 imatinib Gleevec ® 67 R#/MEM # 67 pharmacogenomic translational research 67 Hsp# Inhibitor 67 cilengitide 67 nicotinic alpha 7 67 Bezielle 67 selective angiogenic kinase inhibitor 67 Zolinza 67 Golimumab 67 nucleoside analog 67 gastrointestinal stromal tumors GIST 67 Liprotamase 67 Litx 66 INTEGRILIN R 66 anthracycline taxane 66 CB2 selective receptor agonist 66 MEK inhibitor 66 alefacept 66 Kamada AAT 66 CTAP# Capsules 66 Initiate Phase 66 Triapine 66 oral nucleoside analogue 66 Muraglitazar 66 basiliximab 66 Maxy G# 66 Prodarsan R 66 Gleevec resistant 66 PSN# [001] 66 ADAGEN 66 riociguat 66 Combination REOLYSIN R 66 reslizumab 66 irinotecan doxorubicin oxaliplatin paclitaxel 66 Vascugel 66 VitiGam 66 ThermoDox R 66 metastatic malignant 66 Ovitrelle R Serostim 66 PRN FDA Approves 66 novel synthetic PEGylated 66 Naive Patients 66 samalizumab 66 Begins Dosing 66 vapreotide acetate 66 Pruvel TM 66 GRNOPC1 contains 66 Sym# 66 alkylating agent 66 HCV NS5B polymerase 66 ® lenalidomide 66 sunitinib malate 66 GW# [003] 66 Erbitux cetuximab 66 Vitrasert R 66 Zalypsis 66 alfa 2a 66 SCIB1 66 Orally administered 66 OvaRex ® MAb 66 HGS ETR1 mapatumumab 66 Pruvel ™ 66 Vincristine 66 Provectus Pharmaceuticals specializes 66 OncoVex 66 NU# direct 66 phase IIb clinical 66 Letairis ambrisentan 66 compound INCB# 66 Bayer HealthCare Onyx Pharmaceuticals 66 TLR7 agonist 66 depsipeptide 66 bortezomib Velcade 66 sulfonylhydrazine class 66 hypereosinophilic syndrome 66 Pafuramidine 66 orally bioavailable 66 PARP inhibitor 66 Initiate Clinical Trial 66 dexamethasone Decadron 66 Aviptadil 66 R sorafenib tablets 66 Cotara ® 66 Pazopanib 66 trial evaluating PRX# 66 TACI Ig 66 Pathway Inhibitor 66 vorinostat 66 cisplatin gemcitabine 66 alkylating 66 CYC# 66 adult mesenchymal stem 66 CD# CEA 66 Dasatinib 66 Bortezomib 66 Successfully Completes Phase 66 Abiraterone acetate 66 Nexavar sorafenib 66 histone deacetylase HDAC inhibitor 66 urocortin 2 66 nilotinib Tasigna 66 factor TNF 66 huC# DM4 66 Pimavanserin 66 haematological malignancies 66 idiopathic thrombocytopenic purpura ITP 66 anti botulism antibody 66 compound PMX # 66 Proxinium TM 66 ATRA IV 66 Ixempra 66 trastuzumab Herceptin R 66 CR# vcMMAE 66 class anticancer quinolone 66 vaccine GRNVAC1 66 ganetespib 66 oral ghrelin agonist 66 Immunotherapeutic 66 small molecule tyrosine 66 Vidaza ® 66 factor VIIa 66 investigational oral inhibitor 66 sodium thiosulfate STS 66 sorafenib Nexavar R 66 Aurora Kinase 66 Saizen ® 66 Azedra 66 blinded randomized placebo controlled 66 psoriasis rheumatoid arthritis 66 histone deacetylase HDAC inhibitors 66 Chemophase 66 PKC# 66 MTP inhibitor 66 cortisol synthesis 66 docetaxel Taxotere ® 66 potent antiproliferative 66 chemotherapy FOLFOX 66 Mg Usa 66 Exherin TM 66 developed preclinically 66 Panzem NCD 66 Maribavir 66 Azacitidine 66 accumulate preferentially 66 ASONEP TM 66 Safinamide 66 Ataluren 66 directed radiotherapeutic antibody 66 CYP#A# isoenzyme 66 Campath ® 66 pancreatic colon 66 Irinotecan 66 Tanespimycin 66 TLR9 agonist 66 generation purine nucleoside 66 siRNA binds 66 oncolytic virus therapies 66 EZN 66 Metastatic Melanoma 66 folate analogue metabolic 66 Folfox 66 PRT# 66 liposomal formulation 66 inhibit metastasis 66 hematological malignancy 66 memantine HCl 66 AKT inhibitor 66 mTOR inhibitor 66 ASG 5ME 66 selective immunoproteasome inhibitor 66 SPRYCEL ® 66 M2 subunit 66 gefitinib Iressa 66 deforolimus 66 refractory cutaneous T 66 delta opioid receptor 66 TM pralatrexate injection 66 Gamunex C 66 rxRNA 66 adenosine A2A 66 interferon beta 1a infertility 66 Hormone Refractory Prostate Cancer 66 VNP#M 66 Crizotinib 66 commercialize deforolimus 66 methylnaltrexone bromide 66 Vascular Disrupting Agent 66 incyclinide 66 Velcade bortezomib 66 monoclonal antibody conjugated 66 Receives Orphan Drug Designation 66 Elesclomol 66 Varespladib 66 HCD# [002] 66 familial amyloidotic polyneuropathy FAP 66 angiogenesis inhibitor 66 investigational protease inhibitor 65 Phase Ib II 65 Angiotensin Converting Enzyme 65 polymerase inhibitor 65 interferon alpha IFN 65 brivanib 65 CBLC# 65 cyclophosphamide chemotherapy 65 systemic sclerosis SSc 65 RANK Ligand inhibitor 65 Dendreon investigational 65 mitoxantrone plus 65 PDX pralatrexate 65 Deforolimus 65 Rituxan rituximab 65 hyaluronidase enzyme 65 factor TNF receptor 65 LEUKINE 65 Anti VEGF 65 rALLy 65 ALTROPANE R 65 small molecule thrombopoietin 65 novel therapeutic antibodies 65 Tykerb lapatinib 65 BRIM2 65 lexidronam injection 65 solid tumors ZYBRESTAT 65 severe hypercholesterolemia 65 IRX 2 65 dual orexin receptor 65 Teriflunomide 65 Talotrexin 65 generation PNP inhibitor 65 oral antiviral 65 myeloproliferative disorders 65 Pivotal Clinical Trial 65 specific lectin receptors 65 NS5b 65 Glufosfamide 65 RhuDex R 65 Dacogen decitabine 65 molecularly targeted 65 induced macular edema 65 HGS ETR1 65 PI3K/Akt pathway inhibitor 65 unique alkylating agent 65 TransVax ™ 65 haematologic malignancies 65 histone deacetylase inhibitor 65 IMC #B 65 adhesion molecule EpCAM expressing 65 targeted antifolate 65 Piperacillin 65 LHRH antagonist 65 relapsed multiple myeloma 65 Janus Kinase 65 pentostatin 65 signal transduction inhibitors 65 TELINTRA R 65 peptibody 65 Ribavirin causes 65 Hedgehog Pathway Inhibitor 65 Phase 1b clinical trials 65 Eltrombopag 65 L Annamycin 65 TNF Tumor Necrosis Factor 65 metastatic hormone refractory 65 Pemetrexed 65 humanized antibody 65 IMPDH inhibitor 65 Initiates Clinical Trial 65 SYN# 65 advanced metastatic renal 65 indolent follicular non 65 glucagon receptor 65 Friedreich Ataxia FRDA 65 Preclinical studies suggest 65 IMC A# 65 Aurora kinase inhibitor 65 Interferon Beta 65 ATL# [001] 65 Xcellerated T Cells 65 NS5B polymerase 65 castrate resistant prostate cancer 65 5 HT6 receptor 65 Complicated Skin 65 systemically administered 65 Eculizumab 65 carmustine 65 Oral Calcitonin 65 Phase IIb Trial 65 antiangiogenic agent 65 Aganocide 65 EMD # 65 cardio renal 65 ® bortezomib 65 SinuNase ™ 65 ALS #-# 65 Submits Biologics License Application 65 imexon 65 hypoxia inducible factor 65 castration resistant hormone refractory 65 Crofelemer budesonide foam 65 Anthracyclines 65 Dose Ranging Study 65 multiple myeloma MM 65 nasal calcitonin product 65 protein kinase inhibitors 65 ARRY # 65 Virulizin ® 65 Bosutinib 65 MyVax R 65 meropenem 65 adecatumumab MT# 65 TNF á 65 corticosteroid dexamethasone 65 nilotinib Tasigna ® 65 Adenoscan R 65 bladder ovarian 65 HER2 positive metastatic breast 65 polycythemia vera essential thrombocythemia 65 Relapsed Refractory 65 FUSILEV ® 65 receptor inhibiting monoclonal 65 nucleotide analogue 65 Hsp# inhibition 65 Phase IIb clinical trials 65 small molecule VR1 65 gemcitabine Gemzar R 65 diarrhea predominant irritable 65 vitreoretinal disorders 65 Aztreonam 65 Ridaforolimus 65 GTC recombinant form 65 Tibotec Therapeutics division 65 anti PlGF 65 Elagolix 65 selective antagonist 65 MET VEGFR2 65 cytostatic 65 Davanat 65 CINQUIL 65 Ixabepilone 65 novel orally administered 65 5 HT3 antagonist 65 Heterozygous Familial Hypercholesterolemia 65 Sphingomab 65 aerosolized AAT 65 Campath alemtuzumab 65 relapsed refractory multiple myeloma 65 delivery polymer matrix 65 intranasal formulation 65 Anthracycline 65 M# rationally 65 OvaRex R 65 imatinib Gleevec 65 BENLYSTA TM 65 human IgG1 monoclonal 65 anti atherothrombotic 65 Ceflatonin R 65 phosphate S1P 65 selective inhibition 65 HCV protease inhibitor 65 TRAIL receptor antibodies 65 Taxotere docetaxel 65 Parathyroid Hormone 65 oral JAK1 65 sodium glucose cotransporter 65 dependent kinase inhibitor 65 non peptidic protease 65 oxaliplatin Eloxatin 65 immunosuppressant drug 65 ocular formulation 65 personalized dendritic cell 65 oral Janus kinase 65 relapsed ALL 65 refractory metastatic 65 Pralatrexate 65 Therapeutic Vaccine 65 GTC recombinant human 65 Ganciclovir 65 Voreloxin 65 ASONEP ™ 65 orally dosed 65 LymphoStat B TM 65 irreversible inhibitor 65 ribonucleotide reductase clinically validated 65 Amrubicin 65 Novolimus 65 Trabectedin 65 R roscovitine CDK cyclin 65 delivered RNAi therapeutic 65 immune modulator 65 Initiates Clinical 65 either acutely decompensated 65 developing Zerenex ferric 65 Antibody Drug Conjugate 65 PANVAC VF 65 BCG refractory carcinoma 65 hyperphenylalaninemia HPA due 65 Dapagliflozin 65 sirtuin inhibitor program 65 non resectable metastatic 65 refractory indolent non 65 mGluR5 NAM 65 sapacitabine CYC# 65 sirtuin inhibitors 65 TTF Therapy 65 biliary tract cancer 65 JAK3 65 CRM# Protein 65 thiazolides 65 Kinoid 64 Vidofludimus 64 dexpramipexole 64 tyrosine kinase inhibitor TKI 64 Oral Fingolimod 64 ISTODAX 64 Nexavar ® 64 thetreatment 64 humanized anti 64 Anidulafungin 64 PORxin TM platforms 64 Symadex 64 chronic eosinophilic leukemia 64 INCB# [003] 64 ProMune 64 mocetinostat MGCD# 64 ixabepilone 64 developing Bicifadine serotonin 64 topoisomerase II inhibitor 64 NOX E# 64 Kit CD# positive 64 Granulocyte Colony Stimulating Factor 64 enzastaurin 64 Cytarabine 64 cutaneous T cell 64 BLyS specific 64 5 FU capecitabine 64 Afatinib 64 Forodesine HCl 64 CDK inhibitor 64 Albuferon TM 64 reversible inhibitors 64 metastatic renal cell 64 Carfilzomib 64 Proellex TM 64 Phase 2a Trial 64 LHRH antagonists 64 Perifosine KRX 64 Gleevec imatinib mesylate 64 IMiDs 64 alpha#beta# integrin 64 CEL SCI Phase III 64 transplantation HCT 64 glycoprotein GP IIb IIIa 64 evaluating T DM1 64 Monoclonal antibody 64 Amigal TM 64 oral proteasome inhibitor 64 enzyme inhibitor 64 TLK# 64 Epothilones 64 Ad5FGF 4 64 Tarvacin Anti Cancer 64 endosomal release 64 small molecule glucokinase 64 Troxatyl 64 XL# XL# 64 flavopiridol 64 humanized interleukin 6 64 Enzyme Replacement Therapy 64 PROSTVAC VF 64 small molecule Hedgehog 64 Triapine R 64 CA4P 64 Xcytrin R 64 polysaccharide polymer 64 Initiates Phase 2b 64 Bucindolol 64 antibody MT# 64 Angiolix R 64 Neuvenge 64 Plicera 64 Pyridorin 64 BioNumerik 64 oral ferric iron 64 vemurafenib 64 CCR5 mAb 64 registrational Phase 64 paclitaxel cisplatin 64 autologous cellular immunotherapy 64 Phase III Clinical Trial 64 pomalidomide 64 sulindac 64 #HT# 64 5 HT2A inverse 64 Exemestane 64 recombinant PSMA vaccine 64 oral isoform selective HDAC 64 Phase 2b Trial 64 Ofatumumab 64 lumiliximab 64 oral JAK#/JAK# inhibitor 64 stage IIIb IV 64 BAY #-# 64 demethylating agents 64 RECOTHROM ® 64 DU #b 64 LPA1 64 selective estrogen receptor modulator 64 partial agonist 64 RhuDex ® 64 Mylan Receives Approval 64 cyclophosphamide methotrexate 64 OncoMed 64 Prodarsan 64 Refractory Hodgkin Lymphoma 64 BZL# 64 huN# DM1 64 soluble tumor necrosis 64 Previously Treated 64 PrevOnco 64 c Raf kinase 64 potent CYP#A# inhibitors 64 Presents Positive 64 Raf kinase 64 SAR# [004] 64 gastrointestinal stromal 64 IV Busulfex 64 azilsartan medoxomil 64 allosteric modulator PAM 64 EOquin TM 64 drug pipeline TAFA# 64 cathepsin K inhibitor 64 oral salmon calcitonin 64 GATTEX TM 64 Sprycel dasatinib 64 malignant ascites 64 dexanabinol 64 tiapamil 64 diagnostic molecular imaging 64 Adjuvant Treatment 64 papillary renal cell carcinoma 64 R bendamustine hydrochloride 64 Fulvestrant 64 Neulasta R 64 allogeneic epidermal 64 Solazed TM 64 benign prostatic hypertrophy BPH 64 reversible inhibitor 64 metastatic ocular 64 Achieves Primary Endpoint 64 Trofex TM 64 First Patient Dosed 64 novel topoisomerase 64 TRIOLEX HE# APOPTONE HE# 64 INCB# [001] 64 metastatic pancreatic 64 vWF 64 Toremifene 64 Tesetaxel 64 Genasense ® oblimersen 64 ZEVALIN ® 64 Temodar ® 64 Anti Tumor 64 Familial Adenomatous Polyposis FAP 64 Monoclonal Antibody 64 motesanib 64 Hematology Molecular Pathology 64 direct thrombin inhibitors 64 EOquin TM phase 64 Nipent R 64 Pivotal Study 64 Investigational Oral 64 Intravitreal 64 Boceprevir 64 multicenter Phase III 64 Thiarabine 64 mGluR2 positive 64 selective phosphodiesterase 64 interferon gamma 1b 64 atrasentan 64 JAK2 Inhibitor 64 Phase Ib clinical trials 64 humanized monoclonal antibody 64 otelixizumab 64 antimetabolite 64 plus prednisone prednisolone 64 Kinesin Spindle Protein KSP 64 related apoptosis inducing 64 thymalfasin 64 ALK inhibitor 64 Fx #A 64 granted Ortec 64 Valproic acid 64 tubulin inhibitor 64 mRNA antagonist 64 assessing T DM1 64 octreotide acetate 64 multicenter Phase II 64 investigational pharmacologically unique 64 HCV RNA polymerase 64 rHuPH# recombinant human 64 bevacizumab Avastin R 64 Selective Electrochemical Tumor Ablation 64 vinca alkaloids 64 Lubiprostone 64 Herceptin trastuzumab 64 infectious diseases autoimmune diseases 64 Gefitinib 64 Arimoclomol 64 hematological cancers notably 64 Resten NG 64 HuMax CD4 64 Wafer polifeprosan 64 Rebif ® 64 aripiprazole Abilify 64 Lisofylline 64 Carcinoid tumors 64 immuno modulatory 64 II Clinical Trial 64 TNFerade ™ 64 Imetelstat 64 Febuxostat 64 enhance ApoA 64 anti mitotic 64 Lenocta 64 OMNARIS HFA 64 selective serotonin 2C receptor 64 Darapladib 64 POTELLIGENT R Technology 64 non splenectomized 64 protein kinase inhibitor 64 interleukin IL -# 64 EVIZON TM 64 Dalbavancin 64 JAK inhibitors 64 personalized cellular immunotherapy 64 Iloperidone 64 tumors GIST 64 Wellstat 64 hematological tumors 64 ara C 64 Humanized Anti 64 HMG CoA reductase inhibitors 64 BIM #A# 64 Obatoclax 64 triggers apoptosis 64 Patients Treated With 64 PLK1 SNALP 64 teplizumab 64 Mg Uk 64 investigational therapies 64 MGCD# [001] 64 fusion enhancers 64 Solazed 64 Cloretazine R VNP#M 64 metastatic sarcomas 64 ONCONASE R 64 Darinaparsin 64 oligodendrocyte progenitor cells 64 OncoVEX GM CSF 64 radiolabeled TM# 64 cetuximab Erbitux 64 Phase IIb Clinical Trial 64 Vitaxin 64 Genasense ® 64 Genentech Rituxan 64 Excellarate TM 64 Pharmacokinetics PK 64 Unit Dose Budesonide 64 HuLuc# 64 JAK inhibitor 64 formerly LymphoStat B 64 receptor blocker 64 DEB# 64 Iluvien ® 64 Simulect 64 Triphendiol 64 Tumor Necrosis Factor 64 Tyrosine Kinase Inhibitor 64 erlotinib Tarceva 64 tremelimumab 64 paclitaxel Taxol R 64 oxypurinol 64 Cloretazine R 64 Inhalation Solution 64 proprietary polysaccharide 64 SAR# [002] 64 HuMax EGFr 64 Drug Candidate 64 MYDICAR ® 64 Diamyd r 64 XmAb ® 64 TNFerade TM 64 Hematide TM 64 INTEGRILIN ® 64 optimized siRNA 64 GGF2 64 2A receptor agonist 64 XL# XL# XL# 64 BRAF mutant 64 demethylating agent 64 pegylated liposomal doxorubicin 64 constipation OIC 64 Patient Enrollment 64 initiated Phase Ib 64 Zarnestra 64 ALN HTT 64 itraconazole Sporanox